Jake Xia
Direttore/Membro del Consiglio presso Hangzhou Qihan Biotech Co., Ltd.
Posizioni attive di Jake Xia
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jake Xia
Precedenti posizioni note di Jake Xia
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Salomon Brothers | Corporate Officer/Principal | - | - |
Morgan Stanley Capital Partners (Private Equity)
 Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Corporate Officer/Principal | - | - |
Formazione di Jake Xia
| Massachusetts Institute of Technology | Doctorate Degree |
| Northeastern University | Graduate Degree |
| Peking University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Cina | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Finance | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
| Salomon Brothers | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
- Borsa valori
- Insiders
- Jake Xia
- Esperienza
